Noida, India

Dipshe Bist


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dipshe Bist: Innovator in Kinase Inhibitor Compounds

Introduction

Dipshe Bist is a notable inventor based in Noida, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes associated with various health conditions.

Latest Patents

Dipshe Bist holds a patent for "Heterocyclic compounds as kinase inhibitor and uses thereof." This patent relates to compounds that are useful in treating conditions associated with Checkpoint kinase (CHK), specifically CHK-1 enzymes. The invention discloses a compound of formula (IA) that exhibits inhibitory activity against CHK-1 enzymes. The patent also outlines methods for treating conditions linked to excessive activity of CHK-1 enzymes, along with pharmaceutical compositions, kits, and methods of synthesis.

Career Highlights

Dipshe Bist is currently associated with Sperogenix Therapeutics Limited, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the creation of effective treatments for various diseases.

Collaborations

Dipshe has collaborated with notable colleagues such as Dhananjay Pendharkar and Sreekanth A Ramachandran. These collaborations have further enriched his research and development endeavors.

Conclusion

Dipshe Bist is a prominent figure in the field of kinase inhibitors, with a patent that showcases his innovative approach to treating conditions related to CHK-1 enzymes. His contributions to Sperogenix Therapeutics Limited and collaborations with esteemed colleagues highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…